Concepedia
Statistics
Publications
167
Citations
7.7K
H-Index
50
Active since
1972
Affiliations
University of California, Davis(Current)
University of California Davis Medical Center
Palmetto Hematology Oncology
Lawrence Livermore National Laboratory
University of California, San Francisco
Sally J. DeNardo is an author at University of California, Davis specializing in medicine, oncology, and radionuclide therapy.
Publications per year
1972–2015
Cilengitide targeting of alpha(v)beta(3) integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenografts.
Sally J. DeNardo, Laird Miers, Kathleen R. Lamborn et al. · PubMed · 2002 · 213 citations
Medicine, Oncology, Pharmacology +17
Development of Tumor Targeting Bioprobes (111In-Chimeric L6 Monoclonal Antibody Nanoparticles) for Alternating Magnetic Field Cancer Therapy
Sally J. DeNardo, Gerald L. DeNardo, Laird Miers et al. · Clinical Cancer Research · 2005 · 197 citations
Copper chelates as probes of biological systems: Stable copper complexes with a macrocyclic bifunctional chelating agent
Min K. Moi, Claude F. Meares, Michael J. McCall et al. · Analytical Biochemistry · 1985 · 193 citations
Natural Sciences, Biochemistry, Chemistry +15
Application of High Amplitude Alternating Magnetic Fields for Heat Induction of Nanoparticles Localized in Cancer
Robert Ivkov, Sally J. DeNardo, Wolfgang Daum et al. · Clinical Cancer Research · 2005 · 186 citations
Natural Sciences, Biomedical Engineering, Oncology +16
Maximum-tolerated dose, toxicity, and efficacy of (131)I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphoma.
Gerald L. DeNardo, Sally J. DeNardo, D S Goldstein et al. · Journal of Clinical Oncology · 1998 · 182 citations
Medicine, Nuclear Medicine, Oncology +17
1–5 of 167